Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Petros Pharmaceuticals (PTPI)

Petros Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PTPI
DateTimeSourceHeadlineSymbolCompany
31/05/202422:07Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
21/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
14/05/202412:00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:PTPIPetros Pharmaceuticals Inc
12/01/202421:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
29/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
28/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202322:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202322:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202321:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202321:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202322:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202322:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PTPIPetros Pharmaceuticals Inc
02/10/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202321:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
15/09/202322:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/09/202321:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
25/08/202322:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
15/08/202322:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
15/08/202322:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
14/08/202322:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
11/08/202321:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PTPIPetros Pharmaceuticals Inc
21/07/202321:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PTPIPetros Pharmaceuticals Inc
13/07/202321:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
28/04/202323:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
28/04/202323:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/04/202323:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/04/202323:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/04/202323:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTPI